Lucosky Brookman LLPrepresentedTitan Partnersin its recent $100 million, private placement of MEI Pharma common stock. In connection with the closing of the transaction, MEI appointed Charlie Lee to its Board of Directors and GSR as its digital asset and treasury management advisor to oversee the implementation of its Litecoin Treasury Strategy.
Charlie Lee and GSR acted as lead investors, alongside the Litecoin Foundation establishing MEI as the first and only publicly traded company to adopt Litecoin as a treasury reserve asset.
Titan Partnersserved as sole placement agent delivering exceptional results with a diverse group of prominent crypto venture capital firms and infrastructure providers.
